Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jatiphaladi is a classical Ayurvedic formulation traditionally prepared as a powder (churna) or tablet (vati) and used to treat a variety of respiratory, digestive, and reproductive health conditions. In modern commercial formulations, such as those developed by Pillcraft and other medical cannabis companies in India, Jatiphaladi is often infused with Vijaya (Cannabis sativa) leaf extract. This formulation is indicated for managing penile hypersensitivity and premature ejaculation by regulating the sensitivity threshold, as well as treating respiratory and gastrointestinal issues like cough, asthma, irritable bowel syndrome (IBS), and diarrhea. The cannabis-infused variants are classified as Schedule E1 drugs in India, requiring strict medical supervision and a prescription due to the presence of regulated plant materials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jatiphaladi.